ATOMT — Atomtrace as Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- CZK166.17m
- CZK166.21m
- CZK21.32m
Annual income statement for Atomtrace as, fiscal year end - December 31st, CZK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.07 | 4.26 | 5.02 | 0.139 | 21.3 |
| Cost of Revenue | |||||
| Gross Profit | -6.18 | -7.26 | -7.42 | -4.08 | 6.75 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 11.2 | 20.7 | 24.5 | 18.1 | 19.3 |
| Operating Profit | -8.16 | -16.5 | -19.5 | -18 | 2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.36 | -16.9 | -20.2 | -18.4 | 1.31 |
| Net Income After Taxes | -8.36 | -16.9 | -20.2 | -18.4 | 1.31 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.36 | -16.9 | -20.2 | -18.4 | 1.31 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.36 | -16.9 | -20.2 | -18.4 | 1.31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.98 | -3.89 | -4.64 | -4.24 | 0.302 |